Valuation: Nipro Corporation

Market Cap 222B 1.41B 1.26B 1.17B 1.06B 1.97B 134B 2B 13.94B 5.55B 70.03B 5.27B 5.16B P/E 2027 *
13.8x
P/E 2028 * 10.5x
Enterprise Value 721B 4.56B 4.09B 3.78B 3.43B 6.4B 434B 6.48B 45.22B 18.01B 227B 17.11B 16.75B EV / Sales 2027 *
1.03x
EV / Sales 2028 * 0.97x
Free-Float
85.55%
Yield 2027 *
2.58%
Yield 2028 * 3.56%
1 day+1.05%
1 week+0.82%
Current month-1.24%
1 month-1.42%
3 months-19.02%
6 months-11.03%
Current year-8.50%
1 week 1,331
Extreme 1331
1,371
1 month 1,292.5
Extreme 1292.5
1,389
Current year 1,292.5
Extreme 1292.5
1,760.5
1 year 1,292.5
Extreme 1292.5
1,760.5
3 years 1,070.5
Extreme 1070.5
1,760.5
5 years 987
Extreme 987
1,760.5
10 years 908
Extreme 908
1,760.5
Manager TitleAgeSince
Director of Finance/CFO 58 2025-05-31
President 58 2025-05-31
Chief Administrative Officer - -
Director TitleAgeSince
Chairman 81 2025-06-25
Director/Board Member 54 2009-05-31
Director/Board Member 58 2009-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+1.05%+0.82%-9.75%+20.13% 1.41B
-0.45%+2.12%-18.93%+10.54% 178B
+0.86%+2.15%-19.13%+16.07% 117B
+0.88%+1.88%+1.66%+36.51% 116B
+1.10%+1.41%-43.56%+6.76% 91.03B
-0.31%-4.72%-3.36%+72.86% 61.89B
-0.32%-0.19%+10.38%+83.80% 55.85B
+0.07%+0.42%+5.94%-22.43% 53.16B
+0.30%+1.70%-11.26%+43.83% 44.35B
+1.02%+0.59%-2.09%-7.88% 33.59B
Average +0.40%+0.79%-9.01%+26.02% 75.15B
Weighted average by Cap. +0.29%+1.25%-12.32%+24.35%

Financials

2027 *2028 *
Net sales 699B 4.42B 3.96B 3.66B 3.32B 6.2B 421B 6.28B 43.81B 17.45B 220B 16.58B 16.23B 727B 4.59B 4.12B 3.81B 3.45B 6.45B 437B 6.52B 45.55B 18.14B 229B 17.24B 16.87B
Net income 15.64B 98.85M 88.69M 82M 74.26M 139M 9.41B 140M 980M 390M 4.93B 371M 363M 20.5B 130M 116M 107M 97.32M 182M 12.34B 184M 1.28B 512M 6.46B 486M 476M
Net Debt 499B 3.15B 2.83B 2.62B 2.37B 4.43B 300B 4.48B 31.28B 12.46B 157B 11.84B 11.59B 481B 3.04B 2.73B 2.52B 2.28B 4.27B 290B 4.32B 30.15B 12.01B 152B 11.41B 11.17B
Projected Income Statement - Annual - Nipro Corporation
Logo Nipro Corporation
Nipro Corp is a Japan-based company mainly engaged in the medical, pharmaceutical, and pharma packaging businesses. It has three segments. The Medical segment consists of the domestic business division and the international business division. The domestic business division sells medical devices related to injections and infusions, artificial organs, high-performance medicines, and dialysis. The international business division, centered on the head office, has medical device manufacturing and sales bases overseas for regional expansion, selling medical devices related to injections and infusions, artificial organs, and diabetes. The Pharmaceutical segment sells pharmaceuticals related to kit preparation containers on a contract basis from pharmaceutical companies. The Pharma Packaging segment sells medical glass products such as glass tubes and ampoules, thermos flasks, and kit preparation containers in Japan.
Employees
38,593
Date Price Change Volume
26-10-29 JP¥1,351.50 +1.05% 1,440,900
26-10-28 JP¥1,337.50 -1.58% 579,700
26-10-27 JP¥1,359.00 +0.67% 561,500
26-10-26 JP¥1,350.00 +0.48% 507,400
26-10-23 JP¥1,343.50 +0.22% 583,400
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - Nipro Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
1,337.50JPY
Average target price
1,956.00JPY
Spread / Average Target
+46.24%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Nipro Corporation
  1. Stock Market
  2. Stocks
  3. 8086 Stock